Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 145Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

The DOI matches its Crossref record; the references it cites are not checked yet.

Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis

Fevery, Johan, Verslype, Chris, Lai, Gillian, Aerts, Raymond, Van Steenbergen, Werner·2007·Digestive Diseases and Sciences

Abstract

Primary sclerosing cholangitis (PSC) can lead to the development of cholangiocarcinoma (CCA). The tumor may present as an intrahepatic focal cholangiocellular carcinoma but more often as a ductal infiltrating desmoplastic lesion. CCA is found synchronously with the diagnosis of PSC in 20-30% and within 1 year in 50%. During later follow-up, the yearly developmental rate of CCA is 0.5-1.5%. Most patients with PSC and CCA do not yet have cirrhosis but present with a severe stenosis at the hilum of the liver. This type of tumor is difficult to diagnose by imaging techniques.(18)F-FDG-PET scanning and CEA or CA 19-9 are not early diagnostic tools. Regular MRI, multislice CT, and repeated endoscopically obtained brush cytology of stenotic lesions are recommended. The recent use of more extensive surgical resection techniques in patients with CCA results in 5-year survival rates of > or =50%. If tumors are small or incidental findings, liver transplantation leads to a 3- to 5-year survival rate of 35%. Pretransplant radiotherapy with 5-FU chemosensitization followed by endoscopic brachytherapy with iridium-192 seems to greatly improve the outcome of transplantation. Treatment with ursodeoxycholic acid may prevent development of CCA.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10620-006-9681-4

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists haven’t been fetched yet

References 103 · Cited by 145

Research works printed but not linked: 2

  1. American Joint Committee on Cancer (2005) AJCC cancer staging. Springer Verlag, New York
  2. Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, Wilson SD, Demeure MJ, Rilling WS, Dua KS, Pitt HA (2002) Improved survival in resected biliary malignancies. Surgery 132:555–563 · DOI

Metadata

Authors
Fevery, J., Verslype, C., Lai, G., Aerts, R., & Van Steenbergen, W.
Affiliations
KU Leuven (BE)
Corresponding author
Fevery, Johan
Venue
Digestive Diseases and Sciences
Published
2007-04-12
Volume
52
Issue
11
Pages
3123-3135
ISSN
  • 0163-2116 (ISSN-L)
  • 1573-2568
OpenAlex
W1990013812
Cited by
145
References
103
Citations by year
2026: 7 · 2025: 7 · 2024: 3 · 2023: 7 · 2022: 2 · 2021: 12 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 9 · 2016: 4 · 2015: 9 · 2014: 8 · 2013: 8 · 2012: 9
FWCI
9.63
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Digestive Diseases and Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
cholangiocarcinoma, primary sclerosing cholangitis, intrahepatic cholangiocarcinoma, synchronous tumors, diagnostic imaging, endoscopic brush cytology, 18F-FDG PET, CA19-9, CEA, liver transplantation, iridium-192 brachytherapy, ursodeoxycholic acid, surgical resection, tumor incidence
MeSH terms
Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols, Belgium, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Biopsy, Brachytherapy, Cholangiopancreatography, Endoscopic Retrograde, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Retrospective Studies, Tomography, X-Ray Computed, Cholangitis, Sclerosing, Incidence, Fatal Outcome, Cholangiocarcinoma, Disease Progression, Endosonography, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis. https://app.cochat.ai/papers/10.1007/s10620-006-9681-4
The paper
Fevery, J., Verslype, C., Lai, G., Aerts, R., & Van Steenbergen, W. (2007). Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-006-9681-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.